Anti-PD-L1 checkpoint inhibitors: Decoding the mystery

July 24, 2019 | City of Hope

An study conducted by Michael Caligiuri, M.D., and Jianhua Yu, Ph.D., unveiled why anti-PD-L1 monoclonal antibodies (mAb) are still effective in fighting tumors that lack PD-L1 receptors on their cells.

Continue Reading

Interventional Pain Medicine: New Hope for Chronic Pain

October 3, 2016 | City of Hope

As cancer survival rates in the United States increase due to improving detection and treatment protocols, a growing number of patients are faced with a new and difficult challenge - living with chronic pain. Interventional pain medicine, a new specialty that draws from several branches of medicine, can provide relief to patients suffering from long-term pain.